Pharmaceutical

Bard on verge of settlement in transvaginal mesh case

mesh Bard on verge of settlement in transvaginal mesh caseC.R. Bard and a woman who claims she was injured by the medical device maker’s defective transvaginal mesh are on the verge of a settlement, just days before the lawsuit was scheduled to go to trial.

Debra Wise’s lawsuit was part of a federal multidistrict litigation in West Virginia. The “pending settlement” was signed off on by U.S. District Judge Joseph Goodwin, and the case was ordered off the active docket in the litigation. Wise’s lawsuit was originally filed in West Virginia state court in the Circuit Court of Cabell County before it was transferred to the federal multidistrict litigation. Wise claimed she had suffered injuries after being implanted with Bard’s Avaulta Plus transvaginal mesh to treat pelvic organ prolapse.

Transvaginal mesh, also known as vaginal mesh or bladder sling, is implanted in the pelvic area to treat common pelvic floor disorders including pelvic organ prolapse and stress urinary incontinence. The Food and Drug Administration (FDA) has warned that complications with the devices are not uncommon, and include mesh eroding inside the body and embedding into tissue causing chronic pain, hemorrhaging, infections, and disability.

Goodwin has presided over seven multidistrict litigation cases involving transvaginal mesh devices, which combined contain more than 70,000 pending cases. About 10,000 of those target Bard.

Source: Law 360